Tata India Pharma & Healthcare Fund Overview
Category Pharma Fund
BMSMONEY Rank -
Rating
Growth Option 21-02-2025
NAV ₹27.55(R) -1.52% ₹31.83(D) -1.52%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 8.93% 19.01% 22.12% 18.13% -%
Direct 10.52% 20.78% 23.96% 19.97% -%
Nifty Pharma TRI 8.49% 16.98% 20.4% 13.51% 6.47%
SIP (XIRR) Regular -1.59% 21.94% 19.46% 20.17% -%
Direct -0.1% 23.77% 21.25% 21.99% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.77 0.43 0.96 3.29% 0.13
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
15.63% -16.33% -10.36% 0.92 10.57%
Top Pharma Fund
Fund Name Rank Rating
Sbi Healthcare Opportunities Fund -
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Tata India Pharma & Healthcare Fund -
Dsp Healthcare Fund -
Uti Healthcare Fund -
Nippon India Pharma Fund -
Mirae Asset Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -

NAV Date: 21-02-2025

Scheme Name NAV Rupee Change Percent Change
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option 27.55
-0.4300
-1.5200%
TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum capital withdrawal option 27.55
-0.4300
-1.5200%
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 27.55
-0.4300
-1.5200%
TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option 31.83
-0.4900
-1.5200%
TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option 31.83
-0.4900
-1.5200%
Tata India Pharma & Healthcare Fund-Direct Plan-Growth 31.83
-0.4900
-1.5200%

Review Date: 21-02-2025

A review of the different performance parameters of the fund is as follows:
  1. Returns: It captures the increment in the investment's value during the investment period, articulated as either a percentage or a monetary denomination. We carefully examined six return parameters of this fund to gauge its performance. The return parameters have been divided into three performance groups: the top 25%, parameters below the top 25% but exceeding the average, and parameters below the average mark. Please find the detailed analysis below.
    1. Top 25%: The fund does not have any return parameter in the top 25% in the category.
    2. Above Average Below the Top 25%: One return parameter of the Tata India Pharma & Healthcare Fund is above average but below the top 25% in the category, as shown below:
      • 3M Return %
    3. Below Average: Five return parameters of the fund are below average in the category, which are listed below:
      • 5Y Return %
      • 3Y Return %
      • 1Y Return %
      • 1M Return %
      • 6M Return %
  2. Risk: It signifies the potential for financial loss or the failure to achieve anticipated returns due to diverse elements. We have analyzed two risk parameters of Tata India Pharma & Healthcare Fund, and divided it into three groups the lowest 25%, below average but above the lowest 25%, and above average. More details are provided below.
    1. Lowest 25%: Tata India Pharma & Healthcare Fund does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: Tata India Pharma & Healthcare Fund has one risk parameter that is below average but above the lowest 25% in the category. These are:
      • Semi-Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the semi-deviation, the greater the risk. The semi-deviation of the fund is 10.57 %.
    3. Above Average: Tata India Pharma & Healthcare Fund has one parameter that is above average which is listed below:
      • Standard Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the standard deviation, the greater the risk. The standard deviation of the fund is 15.63 %.
  3. Risk Adjusted Performance Parameters: In mutual funds, risk-adjusted performance parameters are evaluation tools that gauge the returns of an investment against the risk taken. They assist investors in comparing various investments, factoring in both risk and returns. We have evaluated four risk-adjusted performance parameters of the fund.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: Tata India Pharma & Healthcare Fund has two risk-adjusted performance parameters of the fund that are in the this group of the category.
      • Sterling Ratio: Tata India Pharma & Healthcare Fund has a Sterling Ratio of 0.96 compared to the category average of 0.93.
      • Sortino Ratio: Tata India Pharma & Healthcare Fund has a Sortino Ratio of 0.43 compared to the category average of 0.43.
    3. Below Average Risk Adjusted Performance Parameters: Tata India Pharma & Healthcare Fund has two risk-adjusted performance parameters of the fund that are below average in the category.
      • Sharpe Ratio: Tata India Pharma & Healthcare Fund has a Sharpe Ratio of 0.77 compared to the category average of 0.79.
      • Treynor Ratio: Tata India Pharma & Healthcare Fund has a Treynor Ratio of 0.13 compared to the category average of 0.14.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -7.82 -6.64
-6.97
-9.04 | -5.72 12 | 13 Average
3M Return % -6.57 -6.02
-6.79
-9.68 | -4.84 6 | 13 Good
6M Return % -8.67 -9.49
-6.24
-17.69 | -0.25 11 | 13 Average
1Y Return % 8.93 8.49
11.55
1.74 | 21.28 9 | 13 Average
3Y Return % 19.01 16.98
19.78
17.06 | 22.67 5 | 8 Average
5Y Return % 22.12 20.40
23.20
19.41 | 25.85 7 | 8 Poor
7Y Return % 18.13 13.51
18.01
16.89 | 18.98 2 | 4 Good
1Y SIP Return % -1.59
1.08
-11.88 | 13.28 8 | 13 Good
3Y SIP Return % 21.94
23.30
20.70 | 27.21 5 | 8 Average
5Y SIP Return % 19.46
20.31
17.57 | 22.93 5 | 8 Average
7Y SIP Return % 20.17
20.75
20.17 | 22.22 4 | 4 Poor
Standard Deviation 15.63
15.52
14.01 | 16.25 5 | 8 Average
Semi Deviation 10.57
10.65
10.12 | 11.03 3 | 8 Good
Max Drawdown % -10.36
-11.33
-13.44 | -9.85 4 | 8 Good
VaR 1 Y % -16.33
-18.16
-22.20 | -15.67 3 | 8 Good
Average Drawdown % -4.14
-5.01
-6.33 | -4.14 1 | 8 Very Good
Sharpe Ratio 0.77
0.79
0.59 | 1.08 4 | 8 Good
Sterling Ratio 0.96
0.93
0.76 | 1.16 3 | 8 Good
Sortino Ratio 0.43
0.43
0.32 | 0.56 4 | 8 Good
Jensen Alpha % 3.29
3.87
0.23 | 8.88 4 | 8 Good
Treynor Ratio 0.13
0.14
0.10 | 0.19 4 | 8 Good
Modigliani Square Measure % 20.93
21.33
17.54 | 27.27 4 | 8 Good
Alpha % 1.98
2.09
-0.60 | 5.31 4 | 8 Good
Return data last Updated On : Feb. 21, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Jan. 31, 2025
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -7.70 -6.64 -6.87 -8.93 | -5.64 12 | 13
3M Return % -6.23 -6.02 -6.48 -9.30 | -4.55 6 | 13
6M Return % -8.00 -9.49 -5.62 -16.99 | 0.61 10 | 13
1Y Return % 10.52 8.49 13.01 3.43 | 22.79 9 | 13
3Y Return % 20.78 16.98 21.22 18.82 | 23.98 4 | 8
5Y Return % 23.96 20.40 24.74 21.24 | 27.02 7 | 8
7Y Return % 19.97 13.51 19.36 18.09 | 20.04 2 | 4
1Y SIP Return % -0.10 2.46 -10.32 | 14.73 8 | 13
3Y SIP Return % 23.77 24.80 22.30 | 28.34 5 | 8
5Y SIP Return % 21.25 21.78 19.27 | 24.02 5 | 8
7Y SIP Return % 21.99 22.11 21.38 | 23.53 2 | 4
Standard Deviation 15.63 15.52 14.01 | 16.25 5 | 8
Semi Deviation 10.57 10.65 10.12 | 11.03 3 | 8
Max Drawdown % -10.36 -11.33 -13.44 | -9.85 4 | 8
VaR 1 Y % -16.33 -18.16 -22.20 | -15.67 3 | 8
Average Drawdown % -4.14 -5.01 -6.33 | -4.14 1 | 8
Sharpe Ratio 0.77 0.79 0.59 | 1.08 4 | 8
Sterling Ratio 0.96 0.93 0.76 | 1.16 3 | 8
Sortino Ratio 0.43 0.43 0.32 | 0.56 4 | 8
Jensen Alpha % 3.29 3.87 0.23 | 8.88 4 | 8
Treynor Ratio 0.13 0.14 0.10 | 0.19 4 | 8
Modigliani Square Measure % 20.93 21.33 17.54 | 27.27 4 | 8
Alpha % 1.98 2.09 -0.60 | 5.31 4 | 8
Return data last Updated On : Feb. 21, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Jan. 31, 2025
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D -1.52 ₹ 9,848.00 -1.52 ₹ 9,848.00
1W -1.22 ₹ 9,878.00 -1.20 ₹ 9,880.00
1M -7.82 ₹ 9,218.00 -7.70 ₹ 9,230.00
3M -6.57 ₹ 9,343.00 -6.23 ₹ 9,377.00
6M -8.67 ₹ 9,133.00 -8.00 ₹ 9,200.00
1Y 8.93 ₹ 10,893.00 10.52 ₹ 11,052.00
3Y 19.01 ₹ 16,854.00 20.78 ₹ 17,617.00
5Y 22.12 ₹ 27,159.00 23.96 ₹ 29,275.00
7Y 18.13 ₹ 32,093.00 19.97 ₹ 35,766.00
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 -1.59 ₹ 11,895.90 -0.10 ₹ 11,993.69
3Y ₹ 36000 21.94 ₹ 49,647.92 23.77 ₹ 50,921.86
5Y ₹ 60000 19.46 ₹ 97,505.70 21.25 ₹ 101,833.32
7Y ₹ 84000 20.17 ₹ 172,555.40 21.99 ₹ 184,076.26
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Tata India Pharma & Healthcare Fund NAV Regular Growth Tata India Pharma & Healthcare Fund NAV Direct Growth
21-02-2025 27.5462 31.8343
20-02-2025 27.9713 32.3243
19-02-2025 27.8686 32.2043
18-02-2025 27.9789 32.3305
17-02-2025 28.1619 32.5407
14-02-2025 27.8874 32.2197
13-02-2025 28.6967 33.1534
12-02-2025 28.5795 33.0166
11-02-2025 28.6052 33.045
10-02-2025 29.3528 33.9073
07-02-2025 29.9964 34.6466
06-02-2025 30.1459 34.818
05-02-2025 30.0178 34.6686
04-02-2025 29.7139 34.3163
03-02-2025 29.2726 33.8053
31-01-2025 29.3322 33.87
30-01-2025 29.1776 33.6902
29-01-2025 28.8606 33.3228
28-01-2025 28.1984 32.557
27-01-2025 28.7635 33.2081
24-01-2025 29.5498 34.1118
23-01-2025 30.1672 34.8232
22-01-2025 29.7821 34.3774
21-01-2025 29.8816 34.4908

Fund Launch Date: 04/Dec/2015
Fund Category: Pharma Fund
Investment Objective: The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.
Fund Description: A) Pharmaceuticals and Healthcare services sector oriented Fund b) Ideal for investors seeking focused investments in Health service and Medicine realated sectors
Fund Benchmark: Nifty Pharma Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.